Vitae Pharmaceuticals, Inc — key financial figures for fiscal year 2015 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2015)

$579.7K

Net Income/Loss (FY2015)

-$44.0M

Total Assets (FY2015)

$61.8M

Total Equity (FY2015)

$54.5M

Cash Flows from Operating Activities (FY2015)

-$38.0M

Source: Vitae Pharmaceuticals, Inc 10-K filing (FY2015). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.